Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2016 Mar 23;6:23454. doi: 10.1038/srep23454

Ca2+ monitoring in Plasmodium falciparum using the yellow cameleon-Nano biosensor

Kishor Pandey 1,2,*, Pedro E Ferreira 1,3,4,*, Takeshi Ishikawa 5, Takeharu Nagai 6, Osamu Kaneko 1,a, Kazuhide Yahata 1,b,*
PMCID: PMC4804237  PMID: 27006284

Abstract

Calcium (Ca2+)-mediated signaling is a conserved mechanism in eukaryotes, including the human malaria parasite, Plasmodium falciparum. Due to its small size (<10 μm) measurement of intracellular Ca2+ in Plasmodium is technically challenging, and thus Ca2+ regulation in this human pathogen is not well understood. Here we analyze Ca2+ homeostasis via a new approach using transgenic P. falciparum expressing the Ca2+ sensor yellow cameleon (YC)-Nano. We found that cytosolic Ca2+ concentration is maintained at low levels only during the intraerythrocytic trophozoite stage (30 nM), and is increased in the other blood stages (>300 nM). We determined that the mammalian SERCA inhibitor thapsigargin and antimalarial dihydroartemisinin did not perturb SERCA activity. The change of the cytosolic Ca2+ level in P. falciparum was additionally detectable by flow cytometry. Thus, we propose that the developed YC-Nano-based system is useful to study Ca2+ signaling in P. falciparum and is applicable for drug screening.


Malaria is caused by the intracellular protozoan parasite Plasmodium, and remains a major global public health problem1. The malaria parasite life cycle is complex and involves several cellular transformation events and multiplication stages, within both the vertebrate host and mosquito vector. The means by which the parasite recognizes and responds to its environment, and the cell signaling mechanisms which regulate progression through the life cycle, are not well understood. Because these signaling mechanisms and downstream pathways likely involve parasite-specific components, they are of interest for characterization in order to identify drug targets. The importance of new drug development is highlighted by the lack of an effective vaccine, and the observed development of parasite resistance against the present regimens of antimalarial drugs. Thus the development and deployment of antimalarial drugs remains an important strategy to target the liver, blood and transmission stages of the malaria parasite.

Malaria parasite infection begins with the inoculation of sporozoite stage parasites by the mosquito, followed by a period of parasite replication in the liver, and then release of merozoite stages into the blood to begin the intraerythrocytic cycle. It is the asexual repetition of red blood cell (RBC) invasion, development, multiplication via schizogony, and RBC rupture to release new merozoites which amplifies the blood stream parasite burden and provokes malarial symptoms and pathology. Some of the intra-erythrocytic parasites transform to non-replicative macro- and microgametocytes, which are the only stages transmissible to mosquitoes following the taking of a blood meal and which mediate sexual stage development in the mosquito midgut. The life cycle completes by the formation of sporozoites with midgut oocysts, and accumulation of these invasive sporozoites in the mosquito salivary gland. Herein we focus on the intraerythrocytic asexual cycle and gametocytes to characterize the storage and flow of calcium (Ca2+).

Calcium is a universal secondary messenger for intracellular signaling in eukaryotic cells and regulates a variety of cellular functions through fluctuation of cytosolic free Ca2+ 2. In malaria parasites Ca2+ has been implicated as a key second messenger and is maintained at a low level in the cytosol3. Ca2+ signaling has an essential role in Plasmodium cell differentiation, motility, egress from and invasion into the RBC in the blood stage parasites, as well as predicted roles in other lifecycle stages4. However, the mechanism of Ca2+ signaling in malaria parasite is not well understood5. Calcium signaling has been shown to trigger the activation of calcium-dependent protein kinases (CDPKs) and proteinases, which in turn stimulate parasite egress from the infected RBC (iRBC)6,7. During the cell invasion step, the secretion of adhesins from the apical microneme organelles is stimulated by Ca2+ through a phospholipase C (PLC) pathway in both Plasmodium falciparum and the distantly related apicomplexan parasite, Toxoplasma gondii8,9. Among several putative intracellular Ca2+ storage compartments in P. falciparum10, the endoplasmic reticulum (ER) is known to regulate cytosolic Ca2+ through the sarco/endoplasmic reticulum Ca2+-ATPase (PfSERCA or PfATP6) pump11,12. Because SERCA has been studied as a target of therapeutic intervention in cancer13, and since P. falciparum genome contains only one SERCA gene14, targeting this essential pathway related to Ca2+ homeostasis in P. falciparum is an appealing approach to antimalarial drug development.

The cell biology of intracellular Ca2+ has been studied using synthetic chemical fluorescent Ca2+ indicators; however, these types of fluorochromes have drawbacks15. Specifically, because the fluorochromes occupy not only the cytosol, but also intracellular compartments such as ER, mitochondria and digestive food vacuole (DV), they are not suitable to evaluate Ca2+ concentration in a specific compartmentalized space in the eukaryotic cells including malaria parasites16. Malaria parasites possess numerous transporters which presumably localize on the membrane of such different intracellular compartments to actively transport chemical compounds across membranes17. For example, Fluo 4-AM is accumulated in the DV of P. falciparum, and the degree of accumulation appears to differ among parasite strains depending on the gene copy number encoding the transporter located on this membrane18. These fluorochromes exhibit a high dissociation constant value not only in mammalian cells but also in malaria parasites, and are therefore not suitable to evaluate the low static Ca2+ concentration of less than 100 nM which is proposed for P. falciparum19. Thus, the investigation of a cytosolic free Ca2+ concentration using chemical Ca2+ indicators must be approached with caution. To overcome these limitations, we consider here a recently designed genetically encoded Ca2+ indicator, yellow cameleon-Nano (YC-Nano) which is ultrasensitive and able to detect nanomolar changes of Ca2+ concentration in mammalian cell lines20. The YC-Nano Ca2+ biosensors were based on cyan fluorescent protein (CFP) fused with the Ca2+ binding protein, calmodulin (CaM), and yellow fluorescent protein (YFP) fused with M13 peptide. The CaM domain binds to M13 peptide in the presence of Ca2+, which in turn shortens the distance and thereby increases fluorescence resonance energy transfer (FRET) efficiency between the two fluorescent proteins. The advantage of the biosensor compared with fluorochromes is the nature of the output, which is the ratio of the emitted YFP signal to the emitted CFP signal. This ratio metric output reduces the artifacts introduced by unstable focusing due to parasite movement during live cell imaging process, which may occur with non-ratiometric indicators such as fluorochromes.

Here we report for P. falciparum the application of YC-Nano and the successful measurement of changes of cytosolic Ca2+. Live cell confocal microscopy revealed that cytosolic Ca2+ was maintained at a low concentration only at the trophozoite stage, and increased as intraerythrocytic development progressed. We show that the mammalian SERCA pump inhibitor thapsigargin (TG) and dihydroartemisinin (dART), a current first-line antimalarial, did not change the cytosolic Ca2+ concentration, indicating that these compounds do not inhibit P. falciparum SERCA pump activity. Docking analysis supported the insensitivity of the parasite to TG and dART. We also demonstrate detection of the FRET signal by a flow cytometry method, indicating that the transgenic reporter parasite is applicable for the high-throughput screening of compounds targeting P. falciparum Ca2+ homeostasis.

Results

Establishment and calibration of the Ca2+ biosensor YC-Nano in the malaria parasite P. falciparum

To monitor the changes of cytosolic free Ca2+ in P. falciparum, we generated transgenic lines expressing fluorescent protein-based Ca2+ biosensors YC-Nano15 or YC-Nano50 driven by the P. falciparum heat shock protein 86 (PfHSP86) constitutive promoter (Fig. 1a). The difference in the sensitivity to Ca2+ between these biosensors results from different lengths of the linker peptide between CaM domain and M13 peptide. The generated transgenic lines showed strong fluorescence signals in the parasite cytosol (Fig. 1b). In order to evaluate Ca2+ sensing capacity, we generated calibration curves using live trophozoite stages of these transgenic parasites. To exclude the indirect influence of Ca2+ in the iRBC cytosol and PV space, iRBC were treated with saponin to permeabilize the RBC and parasitophorous vacuole membrane (PVM) surrounding the parasite. The ratio of YFP and CFP was determined by confocal microscopy with Tyrode’s buffer containing different concentrations of Ca2+ (0–500 nM). The obtained calibration curves revealed a dissociation constant value of 15.5 nM and 45.8 nM for YC-Nano15 and YC-Nano50, respectively (Fig. 1c). These values are in agreement with the observed values by in vitro Ca2+ titration for those biosensors expressed in Escherichia coli; 15.8 nM and 52.5 nM, respectively20. Thus, our results indicate that malaria parasites efficiently express functional YC-Nano biosensors in the parasite cytosol. Because reports showed that the concentration of free Ca2+ in the parasite cytosol was roughly 40–100 nM by using synthetic chemical fluorescent Ca2+ indicator Fura 221, consistent with our preliminary data using generated transgenic parasites, we selected YC-Nano50 for further experiments to monitor Ca2+ in P. falciparum cytosol, which has a more suitable dynamic range than YC-Nano15 for this purpose.

Figure 1. Design and properties of YC-Nano Ca2+ biosensors in P. falciparum.

Figure 1

(a) Graphic representation of plasmid construction. Amino acid sequences of the linker between calmodulin (CaM) and myosin light chain (M13) peptide for YC-Nano15 and YC-Nano50 are shown. (b) Live cell images of the trophozoite stage parasite. Bright field (BF), CFP, YFP, and FRET (YFP/CFP) signals and merged image (BF-CFP-YFP). Purple to red color scale in the YFP/CFP panel represents low to high FRET efficiency (0 to 2.5). Scale bar, 2.5 μm. (c) The normalized fractional changes of the FRET signals (ΔR/R0) are plotted against the different Ca2+ concentration (0, 20, 40, 60, 80, and 100 nM). The curves represent the averaged data of ten parasites from 3 independent experiments.

Resting cytosolic Ca2+ concentration of intraerythrocytic P. falciparum

To describe the constitutive expression of the fluorescent proteins, we examined the YC-Nano50 fluorescence throughout the malaria parasite life cycle in RBC in addition to the trophozoite stage. We detected fluorescent signals from all blood stages (amoeboid ring, schizont and merozoite stages) and gametocytes, at higher FRET signals than in the trophozoite stage (Fig. 2a). To estimate the resting Ca2+ concentration of the parasite cytosol from FRET signals, we used the in situ Ca2+ calibration method with the Grynkiewicz equation22 (Supplementary Fig. S1). Addition of 10 mM Ca2+ containing the calcium ionophore A23187 to the Ca2+ free parasite culture increased YFP/CFP ratio from 1.36 (Ca2+ = 2.93 nM (median); minimum between 0–30 sec) to 2.66 (Ca2+ = 895.2 nM; maximum between 120–180 sec) in trophozoite stage parasites, confirming that YC-Nano50 has a large dynamic range in P. falciparum. The calculated median cytosolic Ca2+ concentration in the trophozoite stage was 30.0 (interquartile range: 5.6–55.0) nM. We found calculated Ca2+ concentrations in other stages of the parasite were much higher; 372.5 (253.0–483.0) nM at ring, 310.0 (256.2–514.9) nM at schizont, 949.6 (785.1–995.2) nM at merozoite, 131.3 (70.1–185.1) nM at gametocyte (stage III) and 521.8 (387.2–942.2) nM at gametocyte (stage IV–V) stages (Fig. 2b).

Figure 2. Cytosolic Ca2+ concentration in the different developmental stages of P. falciparum.

Figure 2

(a) FRET signals from amoeboid ring (n = 11), trophozoite (n = 18), schizont (n = 10), merozoite (n = 10), and gametocyte (stage III (n = 6) and stage IV-V (n = 7)) stages of the parasite. Bright field (BF), merged image of BF, merged image (BF-CFP-YFP), FRET (YFP/CFP) signals, and calculated Ca2+ concentration with pseudo color are shown. Purple to red color scale in FRET (YFP/CFP) signals and calculated Ca2+ concentration represent low to high FRET efficiency (0 to 2.5) and 0 to 1000 nM Ca2+, respectively. Scale bar, 4 μm. (b) Calculated cytosolic Ca2+ concentrations of parasites with median and interquartile range are shown for each stage. **p = 0.0012, ***p < 0.0001 by Mann-Whitney U-test.

P. falciparum cytosolic Ca2+ level is not modulated by thapsigargin, a mammalian SERCA inhibitor

The endoplasmic reticulum is an important Ca2+ storage compartment to maintain and regulate the cytosolic Ca2+ concentration in eukaryotic cells, and uptake of Ca2+ from cytosol to ER is regulated by SERCA. In Plasmodium conflicting reports describe the responses of malaria parasites against SERCA inhibitors, specifically thapsigargin (TG)21,23. We therefore revisited the effect of TG for parasite cytosolic Ca2+ homeostasis, and found that 15 μM CPA, a SERCA specific inhibitor consistently reported to inhibit P. falciparum SERCA (PfSERCA)24, increased the cytosolic Ca2+ (Fig. 3a); whereas 7.6 μM TG, a concentration reported to inhibit PfSERCA pump activity23, did not change the cytosolic Ca2+ concentration (Fig. 3b). The effect of TG on the cytosolic Ca2+ level was not observed even when 76 μM TG was applied (Supplementary Fig. 2). The positive control calcium ionophore A23187 increased the cytosolic Ca2+, and a solvent control DMSO showed no effect (Fig. 3c,d).

Figure 3. Effect of cyclopiazonic acid (CPA) and thapsigargin (TG) on cytosolic Ca2+ levels in P. falciparum and their docking models.

Figure 3

(a) Time course of the cytosolic Ca2+ level with the addition of 15 μM CPA at 30 sec (arrow). The traces were generated from the mean and standard error of the mean. (n = 4). (b) Time course of the cytosolic Ca2+ level with the addition of 7.6 μM TG at 30 sec (arrow) and 15 μM CPA at 240 sec (arrow, n = 5) (c) Time course of the cytosolic Ca2+ level with the addition of 10 μM A23187 at 30 sec (arrow, n = 3) (d) Time courses of the cytosolic Ca2+ level with the addition of DMSO as a solvent control at 30 sec (arrow, n = 3). The cytosolic Ca2+ level is represented by R/R0 value, where R is the YFP/CFP ratio and R0 is the mean YFP/CFP ratio before addition of the drug as baseline (time between 0–30 s). Model structures of TG (yellow) with human SERCA (HsSERCA) (e) or P. falciparum SERCA (PfSERCA) (f) Illustrate a structural difference in the TG-binding pocket. Colored regions of each SERCA are located within 4.0 Å distance from TG and were used for binding energy calculations. (g,h) Schematics represent surface structure from ribbon diagrams corresponding to (e,f), respectively.

Because the parasite is surrounded by Ca2+ rich environments in the human body and in the culture - for example, 45–86 nM in the RBC cytosol, ~40 μM in the PV space, and ~1 mM in the human plasma25,26 - we further evaluated the effect of CPA and TG in Ca2+-free medium after selective membrane permeabilization. Firstly, iRBCs were treated with streptolysin O (SLO) to selectively permeabilize the RBC membrane, but not the PVM and parasite plasma membrane (PPM). When TG was added to SLO-treated iRBC, no effect was observed, but subsequent addition of CPA increased the cytosolic Ca2+ (Supplementary Fig. S3a), consistent with the previous result, thus indicating that the observed effect of CPA and TG was not due to Ca2+ in the RBC cytosol or medium. Next, iRBCs were treated with saponin to permeabilize the RBC membrane and PVM, but not the PPM. Again CPA increased cytosolic Ca2+, but TG did not (Supplementary Fig. S3b), indicating the effect of CPA and TG was not due to Ca2+ in the PV space. These results confirmed that the parasite cytosolic Ca2+ concentration changed in response to CPA in the presence or absence of RBC membrane and parasitophorous vacuole membrane, indicating that CPA targeted intracellular Ca2+ storage.

To gain insights into the difference between human SERCA and PfSERCA in the response against TG, we constructed a model structure of human SERCA and PfSERCA based on the co-crystal structure of rabbit SERCA with TG using homology modeling. Docking simulation with 200 individual genetic algorithm from homology modeling resulted in an estimated binding free energy and inhibitory constant (KI) for TG and PfSERCA of −9.58 kcal/mol and 95.62 nM, respectively; whereas those for TG and human SERCA were −10.82 kcal/mol and 11.77 nM, respectively. A more negative free energy value indicates a stronger molecular interaction, and thus the results suggest a 8.1-fold weaker interaction between PfSERCA and TG than that between human SERCA and TG. Next, to optimize the interaction between protein and TG in detail, we performed energy minimizations from homology modeling, then we made an energy minimized structure of complex of human SERCA and PfSERCA with TG (Fig. 3e–h). Interaction energy was calculated as the van der Waals force between TG and the 34 amino acids located within 4.0 Å distance from TG (Supplementary Figs S4 and S5). Five amino acid residues (F256, V263, I829, F824, and M838 for human SERCA versus F264, I271, I1041, L1046 and I1050 for PfSERCA) at the same position in the SERCA structure indicated a difference of TG binding pocket and binding energy. For example, L1046 of PfSERCA occupied the location where F834 of human SERCA exists, which results in more open space in the TG-binding pocket of PfSERCA. The total value between PfSERCA and TG was −99.0, a value higher than that between human SERCA and TG (−100.8). Because a more negative value of the estimated van der Waals force indicates more stability, these results also suggest that the interaction between PfSERCA and TG is less stable than that between human SERCA and TG. These homology modeling and binding energy calculations between PfSERCA and TG support the hypothesis of P. falciparum insensitivity against TG.

Dihydroartemisinin does not alter the cytosolic Ca2+ homeostasis of P. falciparum

Artemisinin (ART) derivatives are currently the most commonly used anti-malarial drugs, due to their low cost and because P. falciparum has not developed resistance against these drugs outside of Southeast Asia1. In spite of their importance for treatment of malaria, the mechanism of action of the active metabolite of the ART derivatives, dihydroartemisinin (dART), in the malaria parasite is still not clearly understood27. Two mechanisms of action have been proposed, the first that dART targets parasite hemoglobin metabolism28 and the second that dART targets SERCA29. Because both dART and TG are sesquiterpene lactones and might act towards SERCA in a similar manner, we evaluated if dART could disturb cytosolic Ca2+ homeostasis as implicated from the latter hypothesis. We exposed parasites to different concentration of dART (1, 10, and 100 μM) and found that dART had no effect on the parasite cytosolic Ca2+ concentration even at 100 μM (Fig. 4a–c). Sequential exposure of the dART-treated parasites to CPA increased cytosolic Ca2+, thus validating that the parasites were responsive to inhibitors. The IC50 of dART used in the above experiment against P. falciparum was 1.5 nM for 24 hours30, confirming the pharmacological activity of dART. These results suggest that dART does not target PfSERCA.

Figure 4. Effect of different concentrations of dihydroartemisinin (dART) on the cytosolic Ca2+ level in P. falciparum.

Figure 4

Time course of the cytosolic Ca2+ level with the addition of 1 (a), 10 (b), and 100 μM (c) dART at 30 sec (arrow) and 15 μM cyclopiazonic acid (CPA) at 360 sec (arrow). The trace was generated from the mean and standard error of the mean of at least 3 independent experiments.

Docking simulation of dART with PfSERCA or human SERCA were performed with 200 individual genetic algorithm from homology modeling resulted that the estimated free energy and KI for PfSERCA and dART were −6.96 kcal/mol and 7.85 μM, respectively. For human SERCA and dART the values for estimated free energy and KI were −7.47 kcal/mol and 3.37 μM, respectively; suggesting, firstly, a 2.3-fold weaker interaction between PfSERCA and dART than that between human SERCA and dART; and, secondly, a much weaker interaction of dART with both human and PfSERCA than the case for TG. These modeling calculations support the observed inactivity of dART against cytosolic Ca2+ homeostasis in P. falciparum.

Ca2+ is stored in compartments other than the ER at the trophozoite stage of P. falciparum

In the present study we detected an increase of cytosolic Ca2+ level in the Ca2+-containing medium with the calcium ionophore A23187, but not CPA, even after SERCA was inhibited with CPA as a SERCA specific inhibitor (Fig. 5a, Supplementary Fig. S6a), thereby indicating that the second peak of Ca2+ level was not derived from the ER. In contrast, addition of CPA to the A23187-pretreated iRBCs in the Ca2+-containing medium did not increase the cytosolic Ca2+ (Supplementary Fig. S6b). Although the ER is the main site of intracellular Ca2+ storage, other intracellular compartments are known to contribute to this process in the phylum Apicomplexa4, and therefore these results suggest that Ca2+ flows into the parasite cytosol either from other Ca2+-storing compartments or from outside of the parasite. To investigate if we could detect the existence of non-ER Ca2+ storage sites using the transgenic reporter parasites, we excluded the Ca2+ source in the iRBC cytosol and medium. iRBC were selectively permeabilized with SLO or saponin and the effect on the cytosolic Ca2+ level was evaluated by sequential addition of CPA and A23187 in the Ca2+ free medium. When A23187 was added to SLO-treated and CPA-pretreated iRBC, cytosolic Ca2+ was increased (Fig. 5b), suggesting that second elevation of Ca2+ level was not due to the influx from medium or RBC cytosol. Next, to exclude the Ca2+ source in the PV space, cytosolic Ca2+ level was evaluated using saponin-treated iRBC in the Ca2+ free medium. Addition of A23187 still increased the cytosolic Ca2+ level in the CPA-pretreated parasites (Fig. 5c), indicating that the second elevation of Ca2+ was not due to influx from the PV. Furthermore, we found that the second peak of cytosolic Ca2+ in the parasites treated with saponin was significantly lower than the peak with SLO (13% reduction; n = 4; p < 0.0001, Mann–Whitney U-test), suggesting that this reduction reflect Ca2+ influx from PV into parasite cytosol in SLO-treated iRBC. These results indicate that our system is able to detect the existence of parasite Ca2+ in the PV space and intracellular Ca2+ storage compartments in addition to the ER.

Figure 5. Effect of the membrane permeabilization of the parasite-infected red blood cells on the cytosolic Ca2+ level in P. falciparum.

Figure 5

Schematic indicates the status of the existence of Ca2+ in the different compartments in the parasite-infected red blood cell (iRBC) without treatment (a), treated with streptolysin O (SLO) (b), or treated with saponin (c). Time courses of the cytosolic Ca2+ level with the addition of 15 μM cyclopiazonic acid (CPA) and 10 μM A23187 to non-treated iRBCs in Ca2+-containing RPMI medium (a), with the addition of 3 μM CPA and 2 μM A23187 to SLO-treated iRBCs in Ca2+ free medium (b), or with the addition of 3 μM CPA and 2 μM A23187 to saponin-treated iRBCs in Ca2+ free medium (c). A lower concentration of CPA and A23187 was used to avoid the damage to the SLO-treated and saponin-treated iRBCs. The traces are generated from the mean and standard error of mean of 4 independent experiments.

Flow cytometry-based system is applicable for drug screens targeting P. falciparum Ca2+ homeostasis

In order to develop a high-throughput method to screen panels of compounds, we examined if flow cytometry could be used to detect FRET signals in the YC-Nano50-expressing P. falciparum (Fig. 6a). In this assay we included another SERCA inhibitor, 2,5-di-tert-butylhydroquinone (BHQ), in addition to CPA and TG, to compare the FRET signals obtained by confocal microscopy (Fig. 3a,b and Supplementary Fig. 6c) and those by flow cytometry. BHQ is known for its structural simplicity and low cost in comparison to other SERCA inhibitors31. The Rpost/Rpre values by flow cytometry were 1.24 ± 0.02 (mean ± standard error of the mean (s.e.m.)), 1.13 ± 0.03, 0.99 ± 0.02, and 0.98 ± 0.02, for CPA, BHQ, TG, and DMSO, respectively (Fig. 6a); indicating that CPA and BHQ, but not TG, affect the cytosolic Ca2+ homeostasis. In the above experiments the IC50 values against P. falciparum for CPA, BHQ, and TG were 1.1 ± 0.06 (mean ± s.e.m.), 0.26 ± 0.01, and 32.8 ± 4.8 μM, respectively; thus validating the pharmacological activity of all compounds (Supplementary Table). Clear correlation (R2 = 0.9956) existed between FRET signals obtained from confocal microscopy and flow cytometry (Fig. 6b).

Figure 6. Detection of the cytosolic Ca2+ change in P. falciparum by flow cytometry.

Figure 6

(a) FRET signals are represented by Rpost/Rpre where Rpre is the YFP/CFP ratio before addition of inhibitors and Rpost is the YFP/CFP ratio after addition of inhibitors. The mean and standard error of the mean of Rpost/Rpre were obtained with 15 μM cyclopiazonic acid (CPA), 2 μM 2,5-Di-t-butyl-1,4-butylhydroquinone (BHQ), 7.6 μM thapsigargin (TG) and DMSO from 3 independent experiments. (b) Correlation of FRET signal values obtained by confocal microscopy and the values by flow cytometry. Maximum of FRET signal changes (Rmax/R0) from microscopic analysis and the FRET signal changes (Rpost/Rpre) by flow cytometry are plotted. Linear regression line and the coefficient of determination (R2 = 0.9956) are shown.

Discussion

In this study we generated transgenic P. falciparum lines which stably express genetically encoded YC-Nano Ca2+ biosensors in the cytosol, and a robust system to monitor Ca2+ concentrations under physiological conditions. This technology enabled us to evaluate the cytosolic Ca2+ concentration of the parasite cytosol at different developmental stages, and to monitor the change in cytosolic Ca2+ levels caused by a panel of compounds proposed to act against the ER-residing Ca2+-ATPase, SERCA. As an initial attempt, to avoid cell damage and obtain reproducible FRET signals without photobleaching, we used a 1% (<3 μW) power of 457 nm laser beams for excitation. Introduction of the Perfect Focus System and galvano scanner enabled stable capture images every 1 second at a 512 × 512 pixel resolution, which is critical to monitor changes in organisms of sizes less than 10 μm diameter, such as the malaria parasite. With these optimizations the FRET signals from this organism became stable for 10 minutes or more.

To our knowledge this is the first report to estimate cytosolic Ca2+ concentrations throughout the blood stages of the malaria parasite. The cytosolic Ca2+ concentration is high for all stages (values for amoeboid ring, schizont, merozoite, gametocyte stage III and gametocyte stage IV-V are 373, 310, 949, 131 and 522 nM, respectively), with the exception of the trophozoite (30 nM) (Fig. 7). The trophozoite is metabolically the most active stage, which may favor a lower cytosolic Ca2+ in order to respond to subtle changes in Ca2+ concentrations. The trophozoite stage parasite is able to quickly recover the cytosolic Ca2+ level after the artificial increase of the Ca2+ level with SERCA inhibitors (Fig. 5), indicating the existence of the SERCA-independent mechanisms to maintain the cytosolic Ca2+ level less than 100 nM. PfATP4 (PF3D7_1211900), a non-SERCA-type Ca2+-transporting P-ATPase which is located on the parasite plasma membrane, may participate to this process32. Because the cytosolic Ca2+ level significantly increased in the schizont stage, both mechanisms appear to be less active in this mature parasite form. The estimated cytosolic Ca2+ concentration was highest at the merozoite stage, significantly higher than the schizont stage (n = 10; p < 0.0001, Mann-Whitney U-test). Ca2+ signaling is known to be involved in the egress of the merozoites from the RBC, as well as the invasion into new RBC by triggering the secretion of microorganelles such as exonemes and micronemes in the merozoite stage parasite7,9. Thus we consider that the observed highest cytosolic Ca2+ level at released merozoites indicates that the Ca2+ secretion signals have been initiated. Glushakova et al. reported that cytosolic Ca2+ level increased at the schizont stage, reaching to 1–10 μM range just prior egress using a chemical indicator Fura Red, which is consistent to our estimated cytosolic Ca2+ concentration of 949 nM at the merozoite stage33. P. falciparum calcium-dependent protein kinase 5 (PfCDPK5) and PfCDPK1 are plant-like protein kinase family members and have been proposed to act during these steps34. Although it is not clear if these PfCDPKs are activated at Ca2+ concentrations as high as the 310 nM estimated at the schizont stage, one report proposed that the Kd value for Ca2+ of a purified beetroot CDPK is 770 nM35. In this regard, Carey et al. successfully observed Ca2+ oscillation during P. berghei sporozoite movement using another calcium biosensor, TN-XXL, which has a Kd of 830 nM36. The higher Ca2+ level in the released merozoites was noted by Biagini et al. using Fluo 4-AM, but the concentration was not determined due to the limited resolution of the system37. After completing RBC invasion, the parasite appears to gradually establish mechanisms to regulate cytosolic Ca2+ level less than 100 nM during ring stage development. Because CDPK1 is also expressed in both male and female gametocytes38, high Ca2+ concentration estimated at the gametocyte stage is consistent with possible CDPK1 activity in the high Ca2+ level environment.

Figure 7. Schematic illustration of the cytosolic Ca2+ homeostasis in P. falciparum.

Figure 7

Blood stage parasites observed in in vitro cultures and their estimated cytosolic Ca2+ concentrations are indicated. In the trophozoite stage parasite, P. falciparum SERCA (PfATP6) is inhibited by cyclopiazonic acid (CPA) and 2,5-Di-t-butyl-1,4-butylhydroquinone (BHQ), but not by thapsigargin (TG) and dihydroartemisinin (dART). CPA and BHQ may also affect PfATP4, a Na+-ATPase located on the parasite plasma membrane (PPM), and inhibit Ca2+ influx from parasite cytosol to parasitophorous vacuole. Expected non-ER Ca2+-containing compartment(s) with potential integral membrane Ca2+ transporters are indicated. Inositol trisphosphate receptor (IP3R) on the ER membrane has been proposed, but the encoding gene has not been identified4.

To validate the robustness of our established system to monitor the Ca2+ concentration in P. falciparum, we conducted four experiments to evaluate: 1) the effect of TG on the P. falciparum cytosolic Ca2+ homeostasis, 2) the effect of dART on the P. falciparum cytosolic Ca2+ homeostasis, 3) the feasibility to detect Ca2+ storage(s) beside ER, and 4) the feasibility to establish a high-throughput method to detect the change of the Ca2+ level by flow-cytometry. Uptake of Ca2+ from cytosol to ER is largely regulated by SERCA; however, there are conflicting observations regarding malaria parasite responses against the SERCA inhibitor TG. One report concluded that PfSERCA was TG-insensitive21, but another reported TG-sensitivity23. This controversy may be in part due to the employed method to monitor the cytosolic Ca2+ with synthetic chemical indicators Fura 2-AM or Fluo 3-AM. Our analysis using a parasite line expressing a biosensor revealed that the Ca2+ concentration at the trophozoite stage was 30 nM, which was much lower than the dissociation constant of Fura 2- or Fluo 3-based indicators (Kd = 140 and 325 nM, respectively). Using the YC-Nano50 biosensor with a Kd value of 45.8 nM, which is superior than the chemical indicators to evaluate Ca2+ concentration at the trophozoite stage of P. falciparum, we were able to clarify that TG had no effect on the Ca2+ homeostasis of P. falciparum. SERCA of apicomplexan parasites, including Plasmodium, is evolutionally more closely related to one of the two types of plant SERCA than to mammalian SERCA39. TG is a plant-derived compound and the plant Ca2+-ATPases have developed insensitivity to TG40, which is in agreement to our observation that PfSERCA is TG-insensitive. Docking models of TG with PfSERCA and mammalian SERCA also suggest a clear difference in the shape of the TG binding pocket between the two SERCA structures. Based on these differences in the sensitivity against TG and the structure of the TG binding pocket, TG may serve as a seed compound for a structure-based drug design to develop selective anti-malarial compounds.

Because both TG and ART are composed of sesquiterpene lactone, and since TG is a highly selective inhibitor for mammalian SERCA41, it was therefore reasoned that both TG and ART would behave in a similar manner towards SERCA. Consistent to this expectation, studies analyzed Ca2+-ATPase activity using PfSERCA expressed on Xenopus oocyte membrane proposed that ART had effect on PfSERCA42,43. However, other experiments did not support that PfSERCA was a target of ART44,45. In this study, we clearly showed that dART had no effect on Ca2+ concentration in the parasite cytosol. Docking models of dART and both SERCA showed that the affinity of dART to both SERCA is at the micromolar level, suggesting that dART may not be effective against both SERCA. Together, our data indicate that dART plays at most a minor role to modulate P. falciparum Ca2+ homeostasis.

The ER is the most important organelle storing Ca2+ in the malaria parasite12,21; but other compartments, such as DV37, mitochondrion46, acidocalcisome10, and PV space47 have also been proposed to act as Ca2+ storage sites (Fig. 7). In this study we indicate the existence of Ca2+ in the P. falciparum PV space by comparing SLO-treated iRBC and saponin-treated iRBC. In P. falciparum, two Ca2+ ATPases, PfSERCA (PfATP6) and PfATP4, have been annotated among the 13 P-type ATPases. PfATP4 is localized on the PPM and is considered to transport not only Na+ but also Ca2+ 32,48. This ATPase is potentially responsible for the difference in the observed higher level of the cytosolic Ca2+ increase after calcium ionophore stimulation in SLO-treated iRBC than that in saponin-treated iRBC. The DV was reported to contain only moderate amounts of Ca2+ and no dynamic changes of the Ca2+ concentration were observed in DV following induced cytosolic Ca2+ bursts37. Although there are some reports of the mitochondria and acidocalcisome as Ca2+ storages, active participation of these compartments to maintain cytosolic Ca2+ homeostasis of malaria parasites is still unclear49.

In conclusion, we generated a transgenic P. falciparum expressing YC-Nano50 biosensor and showed that this parasite is a suitable and powerful tool in which to study Ca2+ homeostasis in the trophozoite stage of P. falciparum. We determined, for the first time, that the resting Ca2+ concentrations at schizont, merozoite, ring, and late gametocyte stages are higher than 300 nM. We also showed that TG and dART did not affect the cytosolic Ca2+ level of trophozoite stage of this parasite. FRET signals are detectable by flow cytometry and correlate with a microscope-based assay, indicating that the developed flow cytometry-based system is applicable for drug screens targeting mechanisms which maintain P. falciparum Ca2+ homeostasis.

Methods

Chemicals

Thapsigargin (TG), cyclopiazonic acid (CPA), calcium ionophore A23187, 2,5-Di-t-butyl-1,4-butylhydroquinone (BHQ), and dimethyl sulfoxide (DMSO) were purchased from Sigma Aldrich Chemical Co (St. Louis, USA). Dihydroartemisinin (dART) was purchased from Tokyo chemical industry Co (Tokyo, Japan). Stock solutions of all drugs were dissolved in DMSO.

Generation of expression plasmids for Ca2+ biosensor

Plasmids for P. falciparum transfection were constructed based on the Invitrogen Multisite Gateway® system (Invitrogen, Carlsbad, CA). DNA fragments encoding YC-Nano15 and -50 were amplified from corresponding plasmid templates by PCR amplification and recombined with pDONR™P2R-P3 to generate pENT23-YC-Nano15 and -50, respectively. Expression vectors, pLN-YC-Nano15 and 50 (Fig. 1a), were generated by LR reaction from pENT23 plasmids described above, pENT41 plasmid containing P. falciparum HSP86 promoter region, pENT12-linker, and pLN-DEST-R43(II) containing a blasticidin-s deaminase (BSD) selectable marker50. Nucleotide sequence data reported are available in the DDBJ Sequenced Read Archive under the accession numbers LC028929 and LC075581. All experiments conducted in this study were approved by the committee for recombinant DNA experiment, Nagasaki University. The methods were carried out in accordance with the approved guidelines.

Parasite lines, culture, and transfection

The P. falciparum Dd2 parasite line was originally obtained from National Institute of Health, USA. The parasites were maintained with O+ human RBC at 2% hematocrit in fibrinogen-free human plasma-containing complete RPMI medium and transfection was performed as described51. At days 4–5 post transfection, drug selection with 2.5 μg/mL BSD (InvivoGen, San Diego, CA) was started and culture was maintained until drug-resistant parasites appeared. The usage of human RBC and plasma was approved by the ethical committee, Institute of Tropical Medicine, Nagasaki University.

Cytosolic Ca2+ measurements

YC-Nano-expressing P. falciparum parasites (3–6% parasitemia) were used for live cell imaging experiments. Ca2+ measurements were performed using trophozoite parasites which were obtained by 5% sorbitol synchronization before 18–24 hr experimentation48. On the day of imaging, parasite cultures were collected and washed twice with 1 ml of 37 °C warmed plasma-free incomplete RPMI medium (ICM). Then 1 ml of 0.25% hematocrit parasite infected-RBC (iRBC) was plated on the glass bottom 35-mm cellviewTM TC treated hydrophilic coated dish (Grenier bio-one, Germany). After keeping the iRBC in the dish for 30 min, ICM were replaced with phenol red- and plasma-free RPMI medium containing 0.5% AlbuMAX® I. Time-lapse imaging was performed at 37 °C using an A1R confocal microscope system configured with an inverted microscope (Ti-E; Nikon, Japan) with 60× or 100× oil objective lens (PlanApo, NA 1.4, Nikon). The inverted microscope configuration acts as a stable system with the Perfect Focus System (PFS, Nikon). The water chamber stage and the objective lens were kept at 37 °C with a temperature controller (Tokai-Hit, Japan). The fluorescence resonance energy transfer (FRET) image analysis between cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) was performed by confocal microscopy. YC-Nano was excited at 457 nm for both CFP and YFP, and emissions were detected for CFP (482/35 nm) and YFP (525/50 nm). Time-lapse images were captured every 1 sec at a 512 × 512 pixel resolution by confocal microscopy. For the first 30 sec, time-lapse images were taken without chemical compounds. Chemical compounds (TG, CPA, dART, A23187, BHQ, and DMSO control) were added directly to the edge of the chamber containing transgenic parasites. The parasite cytosolic region was used for the analysis as a region of interest (ROI) and background fluorescence was subtracted. The imaging analysis was carried out using NIS-Element Advanced Research imaging software (Nikon). The R/R0 value was calculated for each parasite, where R is the YFP/CFP ratio and R0 is the mean YFP/CFP ratio before adding the drug as baseline (time between 0–30 s).

Permeabilization of parasite-iRBC with streptolysin O or saponin

To selectively permeabilize the RBC membrane only, iRBC were treated with 20 U/ml streptolysin O (SLO; Sigma Aldrich Chemical Co, St. Louis, MO) in PBS for 6 min at room temperature, washed three times with ICM, and kept in ICM52. To permeabilize RBC and PVM, iRBCs were treated with 0.01% saponin (Wako Pure Chemical Industries, Ltd, Japan) in PBS for 10 min at room temperature, washed three times with PBS, and kept in ICM53. SLO- or saponin-treated iRBCs were transferred to hydrophilic-coated dish and kept for 30 min to let the iRBCs adhere to the glass dish bottom. The iRBCs were washed three times for 10 min each with Ca2+ free Tyrode’s buffer (140 mM NaCl, 10 mM glucose, 10 mM HEPES, 4 mM KCl, 1 mM MgCl2, pH 7.4) to remove Ca2+ from the extracellular medium. Finally, Ca2+ free Tyrode’s buffer was used for time lapse imaging.

YC-Nano calibration curve for P. falciparum

To generate the calibration curve, iRBCs were permeabilized with saponin and prepared for analysis as described above. Tyrode’s buffer containing different concentration of Ca2+ (0, 10, 20, 40, 60, 80, 100, and 500 nM) were prepared with calcium chloride. Parasites were re-suspended in the different concentrations of Ca2+-containing buffer, kept for 10 min, and observed under the confocal microscope. Images were obtained from 10 independent parasites for each Ca2+ concentration and the fractional change of the YFP to CFP ratio (ΔR/R0 where ΔR = R − R0) was calculated. The ΔR/R0 values were normalized by dividing by the ΔR/R0 value with 500 nM Ca2+ buffer and plotted using GraphPad Prism6 software (GraphPad Software, Inc., La Jolla, CA).

Calculation of the resting cytosolic Ca2+ concentration

To estimate the resting cytosolic Ca2+ concentration in the different stages of P. falciparum, we employed an in situ Ca2+ calibration method with time course change of Ca2+ concentration in the individual intact iRBC, which is more precise than single images of the parasite54. The area of the parasite desired for quantification of the fluorescence signal, and the control area were selected as ROIs. YFP/CFP was determined in a given time course. The YFP/CFP value was converted to calcium concentration value using the following equation22. Concentration of free ionized Ca2+ Inline graphic where Kd is a dissociation constant (45.8 nM for YC-Nano50 from Fig. 1), the viscosity is 1 in Ca2+ free Tyrode’s buffer or plasma-free RPMI medium containing 0.5% AlbuMAX® I. Rmin and Rmax are the minimum or maximum YFP/CFP values obtained from trophozoite stage parasites with 1 mM EGTA and 10 μM A23187 (Ca2+-free condition) or with 10 mM CaCl2 and 10 μM A23187 (Saturated Ca2+ condition), respectively. Fmin and Fmax are the fluorescence intensities at 458 nm excitation at the moment of Rmin or Rmax. Obtained Rmin, Rmax, Fmin, and Fmax values were 1.36, 1233, 2.66, and 503, respectively. The different stages of P. falciparum were assayed in plasma-free RPMI medium containing 0.5% AlbuMAX® I. The acquisition of FRET images and the calculation of the resting cytosolic Ca2+ concentration were performed using NIS-Element Advanced Research imaging software (Nikon) with the above formula. For example, Ca2+ concentration of one schizont was calculated as 345.6 nM using above equation from YFP/CFP value of 2.34. Obtained Ca2+ concentration using Grynkiewicz equation with above condition was limited to 1000 nM to avoid unacceptably large fluctuations by NIS-Element Advanced Research imaging software.

Flow cytometry-based Ca2+ measurement

The FRET signal of parasites was measured by flow cytometry (GalliosTM, Beckman Coulter, Inc., Brea, CA). Before assay parasite-iRBCs were washed twice in phenol red- and plasma-free RPMI medium containing 0.5% AlbuMAX® I. To measure CFP and FRET signals, iRBC were excited with a 405 nm laser and fluorescence was collected in the CFP channel with a standard 450/50 filter, while the FRET signal was measured with a 525/20 filter. To measure YFP signal, parasite-iRBCs were excited with a 488 nm laser and emission was taken with 525/20 filter. For each sample a minimum of five thousand YFP positive iRBCs were evaluated and non-infected RBCs were used as a baseline for signal detection. To measure the changes of cytosolic Ca2+, baseline Ca2+ levels were first measured for 60 sec for each sample, followed by addition of different Ca2+ inhibitors (CPA, TG and BHQ) for 3 min. FlowJo software (FlowJo LLC, OR, USA) was used to analyze the obtained data. The mean fluorescence intensities of the iRBC before and after adding inhibitors were obtained and the Rpost ratio of iRBC after adding inhibitors were normalized by Rpre of iRBC before adding inhibitors to obtain the FRET signal changes of each inhibitor.

Drug sensitivity assay

P. falciparum drug sensitivity was assessed using a SYBR® Green I (Lonza Ltd, Basel, Switzerland), assay to determine IC50 using a protocol available at WorldWide Antimalarial Resistance Network (WWARN- http://www.wwarn.org/sites/default/files/INV08_PFalciparumDrugSensitivity.pdf).

Homology modeling, docking simulation, and fragment molecular orbital calculation

The coordinates of the crystal structure of complex between rabbit SERCA and TG was downloaded from the Protein Data Bank (http://www.rcsb.org; 2AGV). A model structure of human SERCA and PfSERCA were generated by a homology modeling based on the rabbit SERCA structure using Modeller9.14 (https://salilab.org/modeller/) 55 and PyMOL (http://www.pymol.org). Binding free energies of TG (PubChem CID: 446378) and dART (PubChem CID: 71939-50-9) with human/PfSERCA were estimated by docking simulations using AutoDock4.256. In these simulations, 200 individual genetic algorithm calculations were run in each of which 25 × 106 energy evaluations were performed. Other model structures of TG and selected 144 amino acid residues located near the binding region were constructed by 2000 steps energy minimizations using AMBER99SB force field57. Using these structures, we performed fragment molecular orbital (FMO) calculations58 at second order Møller-Plesset perturbation theory with resolution of the identity approximation for analysis of van der Waals interactions. In these FMO calculations, cc-pVDZ basis set59 was employed and PAICS program60 was used.

Statistical analyses

All statistical analysis was performed by Graphpad Prism 6 software (GraphPad Software, Inc. CA. USA).

Additional Information

How to cite this article: Pandey, K. et al. Ca2+ monitoring in Plasmodium falciparum using the yellow cameleon-Nano biosensor. Sci. Rep. 6, 23454; doi: 10.1038/srep23454 (2016).

Supplementary Material

Supplementary Information
srep23454-s1.doc (1.8MB, doc)

Acknowledgments

We are grateful to Japanese Red Cross Blood Society for providing human RBC and plasma. We also thank Tanaka R, Ogoshi (Sakura) M and Matsumoto N for technical assistance and Templeton TJ for critical reading. This study was conducted at the Joint Usage / Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University, Japan. KP was a Tokyo Biochemical Research Foundation (TBRF, http://www.tokyobrf.or.jp) post-doctoral fellow and PEF was a Japanese Society of Promotion Sciences (JSPS) post-doctoral fellow. This work was supported in part by the TBRF (K.P.), JSPS (P.E.F.), Takeda Science Foundation (K.Y.), Grants-in-Aids for Scientific Research 24590509 (K.Y.), 22390079 (O.K.), and for Scientific Research on Innovative Areas 23117008 (O.K.), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Footnotes

Author Contributions K.P., P.E.F., T.I., O.K. and K.Y. conceived and designed the experiments. K.P., P.E.F., T.I. and K.Y. performed experiments. T.N., O.K. and K.Y. contributed reagents/materials/analysis tools. K.P., P.E.F., O.K. and K.Y. wrote the paper, and all authors contributed to the manuscript and analyzed the data.

References

  1. World Health Organization. World Malaria Report. (2014). Available at: http://www.who.int/malaria/publications/world_malaria_report_2014/en/. (Accessed: 24/6/2014).
  2. Clapham D. E. Calcium signaling. Cell 131, 1047–1058 (2007). [DOI] [PubMed] [Google Scholar]
  3. Camacho P. Malaria parasites solve the problem of a low calcium environment. J. Cell Biol. 161, 17–19 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lourido S. & Moreno S. N. The calcium signaling toolkit of the apicomplexan parasites Toxoplasma gondii and Plasmodium spp. Cell Calcium 57, 186–193 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Sibley L. D. How apicomplexan parasites move in and out of cells. Curr. Opin. Biotechnol. 21, 592–598 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dvorin J. D. et al. A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes. Science 328, 910–912 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Withers-Martinez C. et al. The malaria parasite egress protease SUB1 is a calcium-dependent redox switch subtilisin. Nat. Commun. 5, 3726 (2014), doi: 10.1038/ncomms4726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carruthers V. B., Moreno S. N. & Sibley L. D. Ethanol and acetaldehyde elevate intracellular [Ca2+ and stimulate microneme discharge in Toxoplasma gondii. Biochem. J. 342, 379–386 (1999). [PMC free article] [PubMed] [Google Scholar]
  9. Singh S., Alam M. M., Pal-Bhowmick I., Brzostowski J. A. & Chitnis C. E. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 6, e1000746 (2010), doi: 10.1371/journal.ppat.1000746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Marchesini N., Luo S., Rodrigues C. O., Moreno S. N. & Docampo R. Acidocalcisomes and a vacuolar H+ -pyrophosphatase in malaria parasites. Biochem. J. 347, 243–253 (2000). [PMC free article] [PubMed] [Google Scholar]
  11. Kimura M., Yamaguchi Y., Takada S. & Tanabe K. Cloning of a Ca2+-ATPase gene of Plasmodium falciparum and comparison with vertebrate Ca2+-ATPases. J. Cell Sci. 104, 1129–1136 (1993). [DOI] [PubMed] [Google Scholar]
  12. Alves E., Bartlett P. J., Garcia C. R. & Thomas A. P. Melatonin and IP3-induced Ca2 + release from intracellular stores in the malaria parasite Plasmodium falciparum within infected red blood cells. J. Biol. Chem. 286, 5905–5912 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Roti G. et al. Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. Cancer Cell 23, 390–405 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gardner M. J. et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498–511 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Biagini G. A., Bray P. G., Spiller D. G., White M. R. & Ward S. A. The digestive food vacuole of the malaria parasite is a dynamic intracellular Ca2+ store. J. Biol. Chem. 278, 27910–27915 (2003). [DOI] [PubMed] [Google Scholar]
  16. Silver R. A., Whitaker M. & Bolsover S. R. Intracellular ion imaging using fluorescent dyes: artefacts and limits to resolution. Pflügers Arch. 420, 595–602 (1992). [DOI] [PubMed] [Google Scholar]
  17. Martin R. E., Henry R. I., Abbey J. L., Clements J. D. & Kirk K. The ‘permeome’ of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol. 6, R26 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rohrbach P. et al. Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J. 25, 3000–3011 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Garcia C. R. et al. Calcium homeostasis in intraerythrocytic malaria parasites. Eur. J. Cell Biol. 71, 409–413 (1996). [PubMed] [Google Scholar]
  20. Horikawa K. et al. Spontaneous network activity visualized by ultrasensitive Ca2+ indicators, yellow Cameleon-Nano. Nat. Methods 7, 729–732 (2010). [DOI] [PubMed] [Google Scholar]
  21. Alleva L. M. & Kirk K. Calcium regulation in the intraerythrocytic malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 117, 121–128 (2001). [DOI] [PubMed] [Google Scholar]
  22. Grynkiewicz G., Poenie M. & Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440–3450 (1985). [PubMed] [Google Scholar]
  23. Varotti F. P., Beraldo F. H., Gazarini M. L. & Garcia C. R. Plasmodium falciparum malaria parasites display a THG-sensitive Ca2+ pool. Cell Calcium 33, 137–144 (2003). [DOI] [PubMed] [Google Scholar]
  24. Laursen M. et al. Cyclopiazonic acid is complexed to a divalent metal ion when bound to the sarcoplasmic reticulum Ca2+-ATPase. J. Biol. Chem. 284, 13513–13518 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rohrbach P. Imaging ion flux and ion homeostasis in blood stage malaria parasites. Biotechnol. J. 6, 812–825 (2009). [DOI] [PubMed] [Google Scholar]
  26. Desai S. Insights gained from P. falciparum cultivation in modified media. The Scientific World Journal 63505 (2013), doi: 10.1155/2013/363505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. O’Neill P. M., Barton V. E. & Ward S. A. The molecular mechanism of action of artemisinin—the debate continues. Molecules 15, 1705–1721 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Klonis N. et al. Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc. Natl. Acad. Sci. USA 108, 11405–11410 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Krishna S., Pulcini S., Fatih F. & Staines H. Artemisinins and the biological basis for the PfATP6/SERCA hypothesis. Trends Parasitol. 26, 517–523 (2010). [DOI] [PubMed] [Google Scholar]
  30. Golenser J., Waknine J. H., Krugliak M., Hunt N. H. & Grau G. E. Current perspectives on the mechanism of action of artemisinins. Int. J. Parasitol. 36, 1427–1441 (2006). [DOI] [PubMed] [Google Scholar]
  31. Moore G. A., McConkey D. J., Kass G. E., O’Brien P. J. & Orrenius S. 2,5-Di(tert-butyl)-1,4-benzohydroquinone—a novel inhibitor of liver microsomal Ca2+ sequestration. FEBS Lett. 224, 331–336 (1987). [DOI] [PubMed] [Google Scholar]
  32. Rottmann M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175–1180 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Glushakova S., Lizunov V., Blank P. S., Melikov K., Humphrey G. & Zimmerberg J. Cytoplasmic free Ca2+ is essential for multiple steps in malaria parasite egress from infected erythrocytes. Malar J. 12(41), (2013), doi: 10.1186/1475-2875-12-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Holder A. A., Mohd Ridzuan M. A. & Green J. L. Calcium dependent protein kinase 1 and calcium fluxes in the malaria parasite. Microbes Infect. 14, 825–830 (2012). [DOI] [PubMed] [Google Scholar]
  35. Lino B., Carrillo-Rayas M. T., Chagolla A. & González de la Vara L. E. Purification and characterization of a calcium-dependent protein kinase from beetroot plasma membranes. Planta. 225, 255–268 (2006). [DOI] [PubMed] [Google Scholar]
  36. Carey A. F. et al. Calcium dynamics of Plasmodium berghei sporozoite motility. Cell Microbiol. 16, 768–783 (2014). [DOI] [PubMed] [Google Scholar]
  37. Biagini G. A., Bray P. G., Spiller D. G., White M. R. & Ward S. A. The digestive food vacuole of the malaria parasite is a dynamic intracellular Ca2+ store. J. Biol. Chem. 278, 27910–27915 (2003). [DOI] [PubMed] [Google Scholar]
  38. Sebastian S. et al. A Plasmodium calcium-dependent protein kinase controls zygote development and transmission by translationally activating repressed mRNAs. Cell Host Microbe 12, 9–19 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Altshuler I., Vaillant J. J., Xu S. & Cristescu M. E. The evolutionary history of sarco(endo)plasmic calcium ATPase (SERCA). PLOS ONE 7, e52617 (2012), doi: 10.1371/journal.pone.0052617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Liang F. & Sze H. A high-affinity Ca2+ pump, ECA1, from the endoplasmic reticulum is inhibited by cyclopiazonic acid but not by thapsigargin. Plant Physiol. 118, 817–825 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Thastrup O., Cullen P. J., Drøbak B. K., Hanley M. R. & Dawson A. P. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA 87, 2466–2470 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Eckstein-Ludwig U. et al. Artemisinin targets the SERCA of Plasmodium falciparum. Nature 424, 957–961 (2003). [DOI] [PubMed] [Google Scholar]
  43. Uhlemann A. C. et al. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat. Struct. Mol. Biol. 12, 628–629 (2005). [DOI] [PubMed] [Google Scholar]
  44. Arnou B. et al. The Plasmodium falciparum Ca2+-ATPase PfATP6: insensitive to artemisinin, but a potential drug target. Biochem. Soc. Trans. 39, 823–831 (2011). [DOI] [PubMed] [Google Scholar]
  45. Cardi D. et al. Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins. J. Biol. Chem. 285, 56406–56416 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rotmann A. et al. PfCHA is a mitochondrial divalent cation/H + antiporter in Plasmodium falciparum. Mol. Microbiol. 76, 1591–1606 (2010). [DOI] [PubMed] [Google Scholar]
  47. Gazarini M. L., Thomas A. P., Pozzan T. & Garcia C. R. Calcium signaling in a low calcium environment: how the intracellular malaria parasite solves the problem. J. Cell Biol. 161, 103–110 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Spillman N. J. et al. Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host Microbe 13, 227–237 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Moreno S. N., Ayong L. & Pace D. A. Calcium storage and function in apicomplexan parasites. Essays Biochem. 51, 97–110 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sakura T., Yahata K. & Kaneko O. The upstream sequence segment of the C-terminal cysteine-rich domain is required for microneme trafficking of Plasmodium falciparum erythrocyte binding antigen 175. Parasitol. Int. 62, 157–164 (2013). [DOI] [PubMed] [Google Scholar]
  51. Deitsch K., Driskill C. & Wellems T. Transfromation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res. 29, 850–853 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Ansorge I., Benting J., Bhakdi S. & Lingelbach K. Protein sorting in Plasmodium falciparum-infected red blood cells permeabilized with the pore-forming protein streptolysin O. Biochem. J. 315, 307–314 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Saliba K. J. & Kirk K. pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a V-type H(+)-ATPase. J. Biol. Chem. 274, 33213–33219 (1999). [DOI] [PubMed] [Google Scholar]
  54. Palmer A. E. & Tsien R. Y. Measuring calcium signaling using genetically targetable fluorescent indicators. Nat. Protoc. 1, 1057–1065 (2006). [DOI] [PubMed] [Google Scholar]
  55. Šali A. & Blundell T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815 (1993). [DOI] [PubMed] [Google Scholar]
  56. Morris G. M. et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Hornak V. et al. Comparison of Multiple Amber Force Fields and Development of Improved Protein Backbone Parameters. Proteins 65, 712–725 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Kitaura K., Sawai T., Asada T., Nakano T. & Uebayasi M. Pair interaction molecular orbital method: an approximate computational method for molecular interactions. Chem. Phys. Lett. 312, 319–324 (1999). [Google Scholar]
  59. Dunning T. H. Gaussian basis sets for use in correlated molecular calculations. I. The atoms boron through neon and hydrogen. J. Chem. Phys. 90, 1007–1023 (1989). [Google Scholar]
  60. Ishikawa T., Ishikura T. & Kuwata K. Theoretical study of the prion protein based on the fragment molecular orbital method. J. Comput. Chem. 30, 2594–2601 (2009). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information
srep23454-s1.doc (1.8MB, doc)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES